WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012100339) METHODS AND COMPOSITIONS FOR THE DETECTION OF PANCREATIC CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/100339    International Application No.:    PCT/CA2012/000078
Publication Date: 02.08.2012 International Filing Date: 27.01.2012
IPC:
G01N 33/48 (2006.01), G01N 33/574 (2006.01), G01N 33/68 (2006.01)
Applicants: UNIVERSITY HEALTH NETWORK [CA/CA]; 190 Elizabeth Street, R. Fraser Elliott Building - Room 1S-417 Toronto, ontario M5G 2C4 (CA) (For All Designated States Except US).
DIAMANDIS, Eleftherios P. [CA/CA]; (CA) (For US Only).
MAKAWITA, Shalini [CA/CA]; (CA) (For US Only)
Inventors: DIAMANDIS, Eleftherios P.; (CA).
MAKAWITA, Shalini; (CA)
Agent: BERESKIN & PARR LLP/S.E.N.C.R.L., S.R.L.; 40th floor 40 King Street West Toronto, Ontario M5H 3Y2 (CA)
Priority Data:
61/436,937 27.01.2011 US
Title (EN) METHODS AND COMPOSITIONS FOR THE DETECTION OF PANCREATIC CANCER
(FR) PROCÉDÉS ET COMPOSITIONS POUR LA DÉTECTION DU CANCER DU PANCRÉAS
Abstract: front page image
(EN)The disclosure includes a method of screening for, diagnosing or detecting pancreatic cancer in a subject, the method comprising: a. determining a level of one or more biomarkers in a sample from the subject, wherein the biomarker(s) is/are selected from the proteins listed in any one of Tables 1 to 4, 7-13, and b. comparing the level of each biomarker in the sample with a control; wherein an increased level of any one of the biomarkers compared to the control is indicative that the subject has pancreatic cancer.
(FR)L'invention concerne un procédé qui sert à dépister, diagnostiquer ou détecter le cancer du pancréas chez un sujet et qui consiste à : a. déterminer un niveau d'un ou plusieurs marqueurs biologiques dans un échantillon prélevé chez le sujet, le(s) marqueur(s) biologique(s) étant sélectionné(s) parmi les protéines répertoriées dans l'un quelconque des tableaux 1 à 4, 7 à 13, et b. comparer le niveau de chaque marqueur biologique dans l'échantillon à un témoin ; un niveau accru de l'un quelconque des marqueurs biologiques comparés au témoin indiquant que le sujet est atteint d'un cancer du pancréas.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)